FDA Inspection 1047623 — Reliance Life Sciences Private Limited
The FDA completed an inspection of Reliance Life Sciences Private Limited on January 25, 2018 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
In Vivo Bioequivalence